Hyundai Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is December - November.

Millions KRW. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Feb '26 Feb 25, 2026	Nov '13 Nov 30, 2013	Nov '12 Nov 30, 2012	Nov '11 Nov 30, 2011	Nov '10 Nov 30, 2010	Nov '09 Nov 30, 2009
Market Capitalization	362,855	42,443	36,229	27,905	38,340	55,972
Market Cap Growth	277.27%	17.15%	29.83%	-27.22%	-31.50%	-0.39%
Enterprise Value	-	48,445	43,620	36,761	49,208	69,151
Last Close Price	13110.00	1585.87	1322.16	994.81	1321.64	1793.06
PE Ratio	217.28	30.00	-	53.65	12.92	33.50
PS Ratio	3.36	0.39	0.35	0.24	0.34	0.46
PB Ratio	3.59	0.42	0.36	0.27	0.41	0.60
P/TBV Ratio	3.67	0.43	0.37	0.28	0.42	0.61
P/FCF Ratio	63.55	7.43	-	10.79	-	-
P/OCF Ratio	45.64	5.34	-	4.45	14.32	-
EV/Sales Ratio	-	0.45	0.43	0.32	0.44	0.56
EV/EBITDA Ratio	-	11.27	-	6.20	35.00	18.32
EV/EBIT Ratio	-	22.15	-	10.62	-	59.08
EV/FCF Ratio	-	8.49	-	14.22	-	-
Debt / Equity Ratio	0.21	0.21	0.29	0.27	0.24	0.25
Debt / EBITDA Ratio	4.83	4.83	-	4.69	15.65	6.23
Debt / FCF Ratio	3.63	3.63	-	10.76	-	-
Net Debt / Equity Ratio	0.06	0.06	0.13	0.13	0.12	0.17
Net Debt / EBITDA Ratio	1.42	1.42	-6.46	2.34	7.60	4.20
Net Debt / FCF Ratio	1.07	1.07	-3.05	5.36	-8.43	-1.72
Asset Turnover	0.74	0.74	0.67	0.79	0.84	0.93
Inventory Turnover	3.00	3.00	3.07	4.41	4.42	4.89
Quick Ratio	1.62	1.62	1.41	1.55	1.80	1.64
Current Ratio	2.20	2.20	1.97	1.94	2.21	2.07
Return on Equity (ROE)	1.45%	1.45%	-4.75%	0.55%	3.21%	1.80%
Return on Assets (ROA)	0.93%	0.93%	-1.76%	1.50%	-0.42%	0.55%
Return on Invested Capital (ROIC)	2.04%	1.99%	-3.75%	0.95%	-0.65%	0.98%
Return on Capital Employed (ROCE)	2.00%	2.00%	-4.10%	3.10%	-0.90%	1.20%
Earnings Yield	0.39%	3.33%	-13.39%	1.86%	7.74%	2.99%
FCF Yield	1.57%	13.45%	-11.47%	9.27%	-3.31%	-16.46%
Dividend Yield	0.23%	-	-	-	3.40%	2.79%
Payout Ratio	62.32%	62.32%	-	202.97%	41.25%	95.71%
Buyback Yield / Dilution	-0.08%	-0.08%	0.90%	0.97%	2.94%	7.44%
Total Shareholder Return	0.14%	-0.08%	0.90%	0.97%	6.34%	10.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.